PUBLISHER: BCC Research | PRODUCT CODE: 1099257
PUBLISHER: BCC Research | PRODUCT CODE: 1099257
The global electroceuticals market should reach $25.5 billion by the end of year 2022 and should reach more than $35.5 billion by year 2027, with a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2022-2027.
The cardioverter defibrillators and cardiac pacemaker product of the global electroceuticals market should reach $12.9 billion by the end of year 2022 and should reach more than $17.7 billion by year 2027 with a CAGR of 6.4% during the forecast period of 2022-2027.
The deep brain stimulation product of the global electroceuticals market should reach $1.2 billion by the end of year 2022 and should reach more than $2.2 billion by year 2027 with a CAGR of 11.5% during the forecast period of 2022-2027.
This report highlights the current and future market potential for electroceuticals. It provides a detailed analysis of the competitive environment, regulatory scenario, and the drivers, restraints, opportunities, and trends in the market. The report also offers market projections through 2027.
This report covers the overall electroceuticals market, including cardiac pacemakers, implantable cardiac defibrillators, hearing aids and implants, and neurostimulation devices. The report also analyzes various end users of electroceuticals.
For this report, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (RoW), which includes Latin America, the Middle East and Africa). Major countries, including the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are analyzed. Market data was provided for 2020, which served as the base year, and forecasts are estimated through 2027. Estimated values are based on product manufacturers' total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.